XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($)
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash Flow From Operating Activities:    
Net Income (Loss) $ (2,775,952) $ 7,295,478
Adjustments to Reconcile Net Income (Loss) to Net Cash Provided by (Used in) Operating Activities:    
Depreciation and Amortization 225,666 521,486
Amortization of Right of Use Asset 117,986 117,986
Amortization of Software Costs 31,425 31,425
Equity Compensation Expense 0 307,686
Value of Equity Issued for Services 228,000 48,000
Reserve for Bad Debt 360,000 205,000
Inventory Reserve 0 (100,000)
Gain Upon Debt Extinguishment (414,583) 0
Decrease (Increase) in:    
Accounts Receivable (171,332) (2,214,625)
Inventory (1,006,689) (1,923,030)
Prepaid Expenses 101,601 (189,095)
Vendor Deposits (38,106) (192,160)
Other Receivables 84,104 (157,487)
Other Assets (195,579) (354,991)
Increase (Decrease) in:    
Accounts Payable (375,248) 1,436,766
Accrued Expenses 157,377 288,508
Accrued Interest 0 (66,667)
Customer Deposits (38,822) 0
Lease Liability (113,039) (109,747)
Net Cash Provided by (Used in) Operating Activities (3,823,191) 4,944,535
Cash Flow From Investing Activities:    
Capitalized Patent and Trademark Costs (45,807)  
Purchase of Property and Equipment (248,751) (50,574)
Net Cash Used in Investing Activities (294,557) (50,574)
Cash Flow From Financing Activities:    
Proceeds from Issuance of Stock and Warrants 4,581,651  
Proceeds from Exercise of Warrants and Options   183,500
Proceeds from Loan Payable   410,700
Repayment of Principal Balance on Convertible Note   (500,000)
Net Cash Provided by Financing Activities 4,581,651 94,200
Increase In Cash and Cash Equivalents 463,904 4,988,160
Cash and Cash Equivalents - Beginning 5,198,842 897,223
Cash and Cash Equivalents - Ending 5,662,746 5,885,383
Supplemental Cash Flow Information:    
Cash Paid for Income Taxes 75,000 800
Cash Paid For Interest   107,356
Non-Cash Investing and Financing Activities:    
Accrued Equity Compensation   27,189
Conversion of Note Payable into Common Stock   4,500,000
Equipment, net Transferred to Inventory   $ 36,256
Patent and trademark costs reclassified from Other Assets $ 67,890